Conservation Will Cost $76 Billion

Researchers estimate annual investment needed to conserve habitats and save the world’s most at-risk species.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The orange-bellied parrot (Neophema chrysogaster) is critically endangered. Wikimedia Commons,, JJ HarrisonWe can now put a price on nature. Protecting the world’s most endangered species from extinction and conserving their habitats will cost $76.1 billion per year, according to estimates published today (October 11) in Science. Though the figure may seem daunting, researchers say it’s a small price to pay for biodiversity.

This amount is "a fraction of what we as consumers spend on soft drinks each year, which is almost half a trillion dollars,” Donal McCarthy, an environmental economist at BirdLife International in Cambridge, UK, and co-author of the study, told BBC News. “The total required for species and sites is less than half of what is paid out in bonuses to bankers on Wall Street's biggest investment banks.”

Moreover, such costs are a fraction of the value of the “ecosystem services” provided by nature, including carbon sinks and crop pollination, estimated to be worth between $2 trillion and $6 trillion. “These sums are not bills, they’re investments in natural capital,” Stuart Butchart, also at BirdLife International and a study co-author, told Nature. “They’re dwarfed by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies